Impact of Angiotensin I-Converting Enzyme Inhibitors and Angiotensin II Type-1 Receptor Blockers on Progression-Free Survival and Overall Survival in Patients With Non-small Cell Lung Cancer

被引：0
|
作者：
Feng, Yun [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai, Peoples R China
来源：
CHEST | 2016年 / 149卷 / 04期
关键词：
D O I：
10.1016/j.chest.2016.02.323
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：310A / 310A
页数：1
相关论文
共 50 条
  • [1] Impact of Angiotensin I-converting Enzyme Inhibitors and Angiotensin II Type-1 Receptor Blockers on Survival of Patients with NSCLC
    Lili Miao
    Wei Chen
    Ling Zhou
    Huanying Wan
    Beili Gao
    Yun Feng
    [J]. Scientific Reports, 6
  • [2] Impact of Angiotensin I-converting Enzyme Inhibitors and Angiotensin II Type-1 Receptor Blockers on Survival of Patients with NSCLC
    Miao, Lili
    Chen, Wei
    Zhou, Ling
    Wan, Huanying
    Gao, Beili
    Feng, Yun
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [3] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review
    Mc Menamin, Una C.
    Murray, Liam J.
    Cantwell, Marie M.
    Hughes, Carmel M.
    [J]. CANCER CAUSES & CONTROL, 2012, 23 (02) : 221 - 230
  • [4] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review
    Úna C. Mc Menamin
    Liam J. Murray
    Marie M. Cantwell
    Carmel M. Hughes
    [J]. Cancer Causes & Control, 2012, 23 : 221 - 230
  • [5] Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy
    Wilop, Stefan
    von Hobe, Sabine
    Crysandt, Martina
    Esser, Albert
    Osieka, Rainhardt
    Jost, Edgar
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (10) : 1429 - 1435
  • [6] Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy
    Stefan Wilop
    Sabine von Hobe
    Martina Crysandt
    Albert Esser
    Rainhardt Osieka
    Edgar Jost
    [J]. Journal of Cancer Research and Clinical Oncology, 2009, 135 : 1429 - 1435
  • [7] Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure
    Edoardo Bertero
    Roberta Miceli
    Alessandra Lorenzoni
    Manrico Balbi
    Giorgio Ghigliotti
    Francesco Chiarella
    Claudio Brunelli
    Francesca Viazzi
    Roberto Pontremoli
    Marco Canepa
    Pietro Ameri
    [J]. Internal and Emergency Medicine, 2019, 14 : 1083 - 1090
  • [8] Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure
    Bertero, Edoardo
    Miceli, Roberta
    Lorenzoni, Alessandra
    Balbi, Manrico
    Ghigliotti, Giorgio
    Chiarella, Francesco
    Brunelli, Claudio
    Viazzi, Francesca
    Pontremoli, Roberto
    Canepa, Marco
    Ameri, Pietro
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2019, 14 (07) : 1083 - 1090
  • [9] Survival impact of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in head and neck cancer
    Stokes, William A.
    Molina, Elizabeth
    McDermott, Jessica D.
    Morgan, Rustain L.
    Bickett, Thomas
    Fakhoury, Kareem R.
    Amini, Arya
    Karam, Sana D.
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2021, 43 (11): : 3255 - 3275
  • [10] Increasing progression-free survival in non-small cell lung cancer
    不详
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2009, 70 (09) : 498 - 498
12345